Clinical Trial Update: Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing immediate prostatectomy to cabozantinib followed by prostatectomy in high-risk non-metastatic prostate cancer was terminated; results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer, Prostate Cancer Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-06-29